FindTrial
Sign In

Effectiveness of oral Gabapentin in supressing nausea and vomiting after neurosurgery

Effect of prophylactic gabapentin on postoperative nausea and vomiting in patients undergoing craniotomy for intracranial tumors- A pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/06/001828
Enrollment
70
Registered
2011-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Prevention of nausea and vomiting

Interventions

Intervention1: Gabapentin: Intervention group to receive 600 mg of oral gabapentin 2 hours before induction of anesthesia Control Intervention1: Placebo: 2 hours before induction of anesthesia

Sponsors

Sree Chitra Tirunal Institute for Medical Sciences and Technology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All elective adult patients posted for craniotomy who are not on gabapentin shall be recruited for this trial

Exclusion criteria

Exclusion criteria: Peditaric and pregnant patients and those operated in emergency shall be excluded from this trial

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomitingTimepoint: 24 hours postoperative—

Secondary

MeasureTime frame
Postoperative pain scoresTimepoint: 24 hours postoperative—

Countries

India

Contacts

Public ContactDrSatyajeet Misra

Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum

misrasatyajeet@gmail.com9995360956

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026